To investigate the influence of EZH2 expression on overall survival and transformation into acute myeloid leukemia (AML), we divided patients into two EZH2 expression groups: low EZH2 expression (RMFI value ≤ median value) and high EZH2 expression (RMFI value > median value). Here, EZH2 is linked to acute myeloid leukemia.